Cargando…

COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Calò, Lorenzo A., Sgarabotto, Luca, Stefanelli, Lucia Federica, Di Vico, Valentina, Davis, Paul A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483540/ https://www.ncbi.nlm.nih.gov/pubmed/36114370 http://dx.doi.org/10.1007/s40620-022-01439-1

Ejemplares similares

Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes
por: Sgarabotto, Luca, et al.
Publicado: (2023)

ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes
por: Calò, Lorenzo A., et al.
Publicado: (2021)

Calcineurin-Inhibitor-Induced Hypomagnesemia in Kidney Transplant Patients: A Monocentric Comparative Study between Sucrosomial Magnesium and Magnesium Pidolate Supplementation
por: Stefanelli, Lucia Federica, et al.
Publicado: (2023)

A Rare Case of Paxlovid-Induced Pancreatitis
por: Zaidi, Syed Muhammad Hussain, et al.
Publicado: (2023)

The Path to Paxlovid
por: Halford, Bethany
Publicado: (2022)

Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
por: Bertoldi, Giovanni, et al.
Publicado: (2023)

Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
por: Bertoldi, Giovanni, et al.
Publicado: (2021)

Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More
por: Ravarotto, Verdiana, et al.
Publicado: (2022)

Transplantation and innate immunity: the lesson of natural killer cells
por: Bertaina, Alice, et al.
Publicado: (2009)

Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
por: Calò, Lorenzo A., et al.
Publicado: (2022)

Paxlovid(TM) Information From FDA and Guidance for AES Members
por: Cokley, Jon A., et al.
Publicado: (2022)

The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study
por: Bertoldi, Giovanni, et al.
Publicado: (2022)

Projected COVID-19 Mortality Reduction From Paxlovid Rollout
por: Khunte, Mihir, et al.
Publicado: (2023)

The road to biosimilars in rare diseases ‐ ongoing lessons from Gaucher disease
por: Drelichman, Guillermo, et al.
Publicado: (2019)

The future of Paxlovid for COVID-19
por: Burki, Talha
Publicado: (2022)

Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023)

The Supporting Role of Combined and Sequential Extracorporeal Blood Purification Therapies in COVID-19 Patients in Intensive Care Unit
por: Nalesso, Federico, et al.
Publicado: (2022)

Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient
por: Shah, Aaisha, et al.
Publicado: (2022)

Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach
por: Rigato, Matteo, et al.
Publicado: (2022)

The patient safety in extracorporeal blood purification treatments of critical patients
por: Nalesso, Federico, et al.
Publicado: (2022)

Pathophysiological lessons from rare associations of immunological disorders
por: Ronco, Pierre, et al.
Publicado: (2009)

An adequate human T cell repertoire from a single T cell progenitor: Lessons from an experiment of nature
por: Canté-Barrett, Kirsten, et al.
Publicado: (2020)

Paxlovid™ jetzt direkt an Patienten abgeben
por: Zimmermann, Gerd W.
Publicado: (2022)

Paxlovid-Induced Symptomatic Bradycardia and Syncope
por: Ganipisetti, Venu M, et al.
Publicado: (2023)

CARDIOGENIC SHOCK DUE TO PAXLOVID INTERACTION
por: Enstrom, Cate, et al.
Publicado: (2023)

Serotonin Syndrome Precipitated by Paxlovid Initiation
por: Nasser, Nicholas G, et al.
Publicado: (2023)

Vaccine hesitancy and other obstacles to COVID-19 control: lessons from smallpox
por: Davis, Robert
Publicado: (2021)

COVID-19 and Senotherapeutics: Any Role for the Naturally-occurring Dipeptide Carnosine?
por: Hipkiss, Alan R
Publicado: (2020)

Lessons from the past
por: Basile, F., et al.
Publicado: (2020)

Erythropoietin and organ protection: lessons from negative clinical trials
por: Pearl, Ronald G
Publicado: (2014)

Lessons learned from the search for genes responsible for rare Mendelian disorders
por: Sobreira, Nara L., et al.
Publicado: (2016)

Rare, rarer, rarest: lessons from the largest retrospective study to date on mediastinal sarcomas
por: den Bakker, Michael A., et al.
Publicado: (2019)

Risks of paxlovid in a heart transplant recipient
por: Stawiarski, Kristin, et al.
Publicado: (2023)

Paxlovid: Mechanism of Action, Synthesis, and In Silico Study
por: Marzi, Mahrokh, et al.
Publicado: (2022)

Carfilzomib Induced Microangiopathy due to Accumulation With Paxlovid
por: Philipponnet, Carole, et al.
Publicado: (2022)

Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner
por: Sotgia, Federica, et al.
Publicado: (2020)

Pathomechanism of oxidative stress in cardiovascular-renal remodeling and therapeutic strategies
por: Ravarotto, Verdiana, et al.
Publicado: (2022)

COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022
por: Wang, Lindsey, et al.
Publicado: (2022)

Lessons learned from COVID-19 pandemic in Italy – A commentary
por: Minni, Antonio, et al.
Publicado: (2021)

Lessons learned from the prenatal microbiome controversy
por: Blaser, Martin J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_th8o9c0goh0ue858n37rba0q37